home / stock / ganx / ganx news


GANX News and Press, Gain Therapeutics Inc. From 11/21/23

Stock Information

Company Name: Gain Therapeutics Inc.
Stock Symbol: GANX
Market: NASDAQ
Website: gaintherapeutics.com

Menu

GANX GANX Quote GANX Short GANX News GANX Articles GANX Message Board
Get GANX Alerts

News, Short Squeeze, Breakout and More Instantly...

GANX - Gain Therapeutics Announces Pricing of $9.4 Million Public Offering and Concurrent Private Placement of Common Stock and Warrants

BETHESDA, Md., Nov. 21, 2023 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (“Gain” or the “Company”) (Nasdaq: GANX) today announced the pricing of an underwritten public offering of 2,213,044 shares of its common stock and warrants to purchase up to an aggregate of ...

GANX - FYBR, MNMD and OM are among after hour movers

2023-11-20 17:34:17 ET Symbotic  ( SYM ) +20% . Veradigm  ( MDRX ) +6% . Tactile Systems Technology ( TCMD ) +6% . Farmer Brothers Company ( FARM ) +4% . Outset Medical ( OM ) +4% . MorphoSys  ( MOR ) -32% ...

GANX - Gain Therapeutics intends to offer its shares in a public offering

2023-11-20 16:08:32 ET More on Gain Therapeutics Seeking Alpha’s Quant Rating on Gain Therapeutics Historical earnings data for Gain Therapeutics Financial information for Gain Therapeutics For further details see: Gain Therapeutics intends to offe...

GANX - Gain Therapeutics Announces Proposed Public Offering

BETHESDA, Md., Nov. 20, 2023 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (“Gain” or the “Company”) (Nasdaq: GANX) today announced that it is proposing to offer and sell, subject to market conditions, shares of its common stock and warrants to purchase common ...

GANX - Gain Therapeutics GAAP EPS of -$0.37

2023-11-14 09:02:00 ET More on Gain Therapeutics Seeking Alpha’s Quant Rating on Gain Therapeutics Historical earnings data for Gain Therapeutics Financial information for Gain Therapeutics For further details see: Gain Therapeutics GAAP EPS of -$0.37

GANX - Gain Therapeutics Announces Third Quarter 2023 Financial Results and Business Update

BETHESDA, Md., Nov. 14, 2023 (GLOBE NEWSWIRE) -- Gain Therapeutics, Inc. (Nasdaq: GANX) (“Gain”, or the “Company”), a clinical-stage biotechnology company leading the discovery and development of the next generation of allosteric small molecule therapies, today announc...

GANX - Expected US Company Earnings on Thursday, November 9th, 2023

Histogen Inc. (HSTO) is expected to report for Q3 2023 News Corporation (NWSA) is expected to report $0.13 for Q1 2024 TORM plc (TRMD) is expected to report for Q3 2023 Blink Charging Co. (BLNK) is expected to report $-0.47 for Q3 2023 Nuvalent Inc. (NUVL) is expected to report $-...

GANX - Expected earnings - Gain Therapeutics Inc.

Gain Therapeutics Inc. (GANX) is expected to report $-0.47 for Q3 2023

GANX - These Apple Insiders Are Selling Shares of AAPL Stock

2023-10-04 09:46:09 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Apple (NASDAQ: AAPL ) stock is a hot topic among traders on Wednesday after several insiders in the tech giant sold shares. One thing that traders will keep in mind is that ...

GANX - Why Is Nvni Group (NVNI) Stock Down 8% Today?

2023-10-04 09:11:28 ET InvestorPlace - Stock Market News, Stock Advice & Trading Tips Nvni Group (NASDAQ: NVNI ) stock is falling on Wednesday after the company recently made its public debut following a special purpose acquisition company (SPAC) merger. ...

Previous 10 Next 10